Yochi Slonim's guest appearances

Yochi Slonim

ForbesBooks Radio

Disruptive CEO Nation

BioBoss

Biotech 2050 Podcast

Shawn Singh

Florian Wegener

Ankit Mahadevia

Michel Detheux

Sven Karlsson

David Berry

David Bates

Jim Sullivan

Tim Sweeney

Tim Miller

Andrew Miller

Chris Wright

James Mackay

Atopic Dermatitis

Thomas Barnes

OwlTail

Anima Biotech

With pandemics and global health concerns in the headlines, it is good to know there are companies like Anima Biotech leveraging advanced technology to accelerate pharma solutions. Under the leadership of Co-founder and CEO Yochi Slonim, the team at Anima Biotech is advancing mRNA Lightning, a novel platform for the discovery of small molecule mRNA drugs and their mechanisms of action. If you do not understand what this means, take a listen as we promise you will be fascinated and learn something new.In this episode, we discussed:- How Yochi made the leap to founding a company that is at the leading edge of the intersection of technology and medical discovery.- How using AI and machine learning is a complete game changer in #medtech.- Why mRNA Lightening is so critical to the swift discovery and treatability process for existing and evolving diseases.- How their differentiated approach combines high-scale phenotypic screening that automates millions of experiments in live mRNA biology with MOAi technology using AI to elucidate the mechanism of action of active molecules.- Why the best people and best solutions require a global team to make up Anima and so their eye is on expansion and partner networks.Yochi Slonim is a serial entrepreneur in software and biotech who has built multiple companies through all phases of growth all the way to IPOs and large M&amp;A exits. As a Co-founder and CEO of Anima Biotech, he is driving the company's vision and strategy, fundraising, and partnering.Prior to Anima, Yochi was a co-founder of Mercury Interactive. As CTO and VP R&amp;D from the company's early days, he created product vision and strategy and led a multi-product organization of 200 developers. After going public and reaching revenues of over $1B annually, Mercury was acquired by HP for $4.5B.In 2000, Yochi was the founder and CEO of Identify. The company reached revenues of $50m in less than 5 years and was acquired by BMC in 2006 for $150m in cash. Yochi founded ffwd.me, a unique startup acceleration program where he led a team that worked with over 25 startups in diverse areas and technologies, developing strategy, products and go-to-market operations while raising multiple rounds of financing from VCs and private investors. Be sure to check out Yochi’s links listed below. Enjoy the show!Connect with Yochi:LinkedIn: https://www.animabiotech.com/Website: https://www.linkedin.com/in/yochislonim/?originalSubdomain=il Connect with Allison:LinkedIn: https://www.linkedin.com/in/allisonsummerschicago/Website: DisruptiveCEONation.comTwitter: @DisruptiveCEO  #CEO #startup #startupstory #founder #founderstory #business #construction #businesspodcast #podcast Learn more about your ad choices. Visit megaphone.fm/adchoices

With pandemics and global health concerns in the headlines, it is good to know there are companies like Anima Biotech leveraging advanced technology to accelerate pharma solutions. Under the leadership of Co-founder and CEO Yochi Slonim, the team at Anima Biotech is advancing mRNA Lightning, a novel platform for the discovery of small molecule mRNA drugs and their mechanisms of action. If you do not understand what this means, take a listen as we promise you will be fascinated and learn something new. In this episode, we discussed:- How Yochi made the leap to founding a company that is at the leading edge of the intersection of technology and medical discovery.- How using AI and machine learning is a complete game changer in #medtech.- Why mRNA Lightening is so critical to the swift discovery and treatability process for existing and evolving diseases.- How their differentiated approach combines high-scale phenotypic screening that automates millions of experiments in live mRNA biology with MOAi technology using AI to elucidate the mechanism of action of active molecules.- Why the best people and best solutions require a global team to make up Anima and so their eye is on expansion and partner networks.Yochi Slonim is a serial entrepreneur in software and biotech who has built multiple companies through all phases of growth all the way to IPOs and large M&amp;A exits. As a Co-founder and CEO of Anima Biotech, he is driving the company's vision and strategy, fundraising, and partnering.Prior to Anima, Yochi was a co-founder of Mercury Interactive. As CTO and VP R&amp;D from the company's early days, he created product vision and strategy and led a multi-product organization of 200 developers. After going public and reaching revenues of over $1B annually, Mercury was acquired by HP for $4.5B.In 2000, Yochi was the founder and CEO of Identify. The company reached revenues of $50m in less than 5 years and was acquired by BMC in 2006 for $150m in cash. Yochi founded <a href="http://ffwd.me" rel="nofollow" target="_blank">ffwd.me</a>, a unique startup acceleration program where he led a team that worked with over 25 startups in diverse areas and technologies, developing strategy, products and go-to-market operations while raising multiple rounds of financing from VCs and private investors. Be sure to check out Yochi’s links listed below. Enjoy the show!Connect with Yochi:LinkedIn: <a href="https://www.animabiotech.com/" rel="nofollow" target="_blank">https://www.animabiotech.com/</a>Website: <a href="https://www.linkedin.com/in/yochislonim/?originalSubdomain=il" rel="nofollow" target="_blank">https://www.linkedin.com/in/yochislonim/?originalSubdomain=il</a> Connect with Allison:LinkedIn: <a href="https://www.linkedin.com/in/allisonsummerschicago/" rel="nofollow" target="_blank">https://www.linkedin.com/in/allisonsummerschicago/</a>Website: <a href="http://DisruptiveCEONation.com" rel="nofollow" target="_blank">DisruptiveCEONation.com</a>Twitter: @DisruptiveCEO  #CEO #startup #startupstory #founder #founderstory #business #construction #businesspodcast #podcast Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices" rel="nofollow" target="_blank">megaphone.fm/adchoices</a>

Episode 179 Yochi Slonim, Co-founder & CEO of Anima Biotech, Bernardsville, New Jersey with offices in Israel, UK and UAE

A serial entrepreneur in software and biotech, Yochi Slonim has built multiple companies as a founder and CEO through all phases of growth all the way to IPOs and large M&amp;A exits. As a Co-founder and CEO of Anima Biotech, he is driving the company's vision and strategy, fundraising, and partnering. Prior to Anima, Yochi was a co-founder of Mercury Interactive. As CTO and VP R&amp;D from the company's early days, he created product vision and strategy and led a multi-product organization of 200 developers. After going public and reaching revenues of over $1B annually, Mercury was acquired by HP for $4.5B.As Senior VP of products and marketing for Tecnomatix, a public NASDAQ company, he led a 500 people organization of 4 divisions that generated revenues of $100m until the company was acquired by UGS for $230m.In 2000, Yochi was founder and CEO of Identify. The company reached revenues of $50m in less than 5 years and was acquired by BMC in 2006 for $150m in cash. Yochi founded ffwd.me, a unique startup acceleration program where he led a team that worked with over 25 startups in diverse areas and technologies, developing strategy, products and go to market operations while raising multiple rounds of financing from VCs and private investors.  As one of Israel's leading speakers on the subject of startup positioning and company building, several of Yochi's approachable and amusing lectures can be found on Youtube ("Youtube Yochi Slonim").

A serial entrepreneur in software and biotech, Yochi Slonim has built multiple companies as a founder and CEO through all phases of growth all the way to IPOs and large M&amp;A exits. As a Co-founder and CEO of Anima Biotech, he is driving the company's vision and strategy, fundraising, and partnering. Prior to Anima, Yochi was a co-founder of Mercury Interactive. As CTO and VP R&amp;D from the company's early days, he created product vision and strategy and led a multi-product organization of 200 developers. After going public and reaching revenues of over $1B annually, Mercury was acquired by HP for $4.5B. As Senior VP of products and marketing for Tecnomatix, a public NASDAQ company, he led a 500 people organization of 4 divisions that generated revenues of $100m until the company was acquired by UGS for $230m. In 2000, Yochi was founder and CEO of Identify. The company reached revenues of $50m in less than 5 years and was acquired by BMC in 2006 for $150m in cash. Yochi founded <a href="http://ffwd.me" rel="nofollow" target="_blank">ffwd.me</a>, a unique startup acceleration program where he led a team that worked with over 25 startups in diverse areas and technologies, developing strategy, products and go to market operations while raising multiple rounds of financing from VCs and private investors. As one of Israel's leading speakers on the subject of startup positioning and company building, several of Yochi's approachable and amusing lectures can be found on Youtube ("Youtube Yochi Slonim").

92. Software driven biology for small molecule mRNA drugs, Yochi Slonim, Co-founder & CEO, Anima

BioBoss host John Simboli speaks with Yochi Slonim, founder and CEO of Anima Biotech, headquartered in Boston with R&amp;D in Tel Aviv.. Hear Yochi's thoughts about leadership in biopharma and how Anima Biotech is working on a novel approach for the discovery of small molecules that selectively control mRNA translation as a new strategy against undruggable proteins.

BioBoss host John Simboli speaks with Yochi Slonim, founder and CEO of Anima Biotech, headquartered in Boston with R&amp;D in Tel Aviv.. Hear Yochi's thoughts about leadership in biopharma and how Anima Biotech is working on a novel approach for the discovery of small molecules that selectively control mRNA translation as a new strategy against undruggable proteins.

#44 - Yochi Slonim: Founder & CEO, Anima Biotech